Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations

International Journal of Cardiology

Volumn 170, Issue 3, 2014, Pages

  Wallentin, Lars ^a   Becker, Richard C ^b   Cannon, Christopher P ^c   Held, Claes ^a   Himmelmann, Anders ^d   Husted, Steen ^e   James, Stefan K ^a   Katus, Hugo S ^f   Mahaffey, Kenneth W ^g   Pieper, Karen S ^b   Storey, Robert F ^h   Steg, Philippe Gabriel ^i,j,k   Harrington, Robert A ^g  

^a UPPSALA UNIVERSITY   (Sweden)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ASTRAZENECA R AND D   (Sweden)

^e REGIONAL HOSPITAL WEST JUTLAND   (Denmark)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁱ INSERM   (France)

^j BICHAT HOSPITAL   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

Acute coronary syndrome; Clinical trial; Clopidogrel; Myocardial infarction; Platelet inhibition; Ticagrelor

Indexed keywords

CLOPIDOGREL; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; DOCUMENTATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; PLATELET INHIBITION AND PATIENT OUTCOMES; PRIORITY JOURNAL; RISK REDUCTION; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; ANALOGS AND DERIVATIVES; BIOASSAY; FOOD AND DRUG ADMINISTRATION; STANDARDS;

ACUTE CORONARY SYNDROME; ADENOSINE; ENDPOINT DETERMINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84891155362     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.11.003     Document Type: Article

References (24)

1. S. James, A. Akerblom, and C.P. Cannon et al. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J 157 4 2009 599 605
2. L. Wallentin, R.C. Becker, and A. Budaj et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 11 2009 1045 1057
3. P.G. Steg, S. James, and R.A. Harrington et al. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis Circulation 122 21 2010 2131 2141
4. C.P. Cannon, R.A. Harrington, and S. James et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 9711 2010 283 293
5. S.K. James, M.T. Roe, and C.P. Cannon et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial BMJ 342 2011 d3527
6. S. James, D.J. Angiolillo, and J.H. Cornel et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial Eur Heart J 31 24 2010 3006 3016
7. S. James, A. Budaj, and P. Aylward et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 122 11 2010 1056 1067
8. S. Husted, S. James, and R.C. Becker et al. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial Circ Cardiovasc Qual Outcomes 5 5 2012 680 688
9. J.H. Cornel, R.C. Becker, and S.G. Goodman et al. Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes - insights from the PLATelet inhibition and patient Outcomes (PLATO) trial Am Heart J 164 3 2012 334 342 [e1]
10. R.F. Storey, R.C. Becker, and R.A. Harrington et al. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes Eur Heart J 32 23 2011 2945 2953
11. R.F. Storey, R.C. Becker, and R.A. Harrington et al. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy) Am J Cardiol 108 11 2011 1542 1546
12. S.K. James, R.F. Storey, and N.S. Khurmi et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack Circulation 125 23 2012 2914 2921
13. P.G. Steg, R.A. Harrington, and H. Emanuelsson et al. Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective randomized PLATO trial Circulation 128 10 2013 Sep 3 1055 1065
14. C. Held, N. Asenblad, and J.P. Bassand et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial J Am Coll Cardiol 57 6 2011 672 684
15. L. Wallentin, S. James, and R.F. Storey et al. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial Lancet 376 9749 2010 1320 1328
16. K.W. Mahaffey, D.M. Wojdyla, and K. Carroll et al. Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 124 5 2011 544 554
17. S.G. Goodman, R. Clare, and K.S. Pieper et al. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial Circulation 125 8 2012 978 986
18. P. Kohli, L. Wallentin, and E. Reyes et al. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study Circulation 127 6 2013 673 680
19. E. Nikolic, M. Janzon, O. Hauch, L. Wallentin, M. Henriksson, and P.H.E.S. Group Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study Eur Heart J 34 3 2013 220 228
20. C.W. Hamm, J.P. Bassand, and S. Agewall et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) G Ital Cardiol (Rome) 13 3 2012 171 228
21. J.L. Anderson, C.D. Adams, and E.M. Antman et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 23 2013 e179 e347
22. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), P.G. Steg, and S.K. James et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 20 2012 Oct 2569 2619
23. J.J. Dinicolantonio, and A. Tomek Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial Int J Cardiol 168 4 2013 Oct 9 4076 4080
24. K.J. Carroll, and T.R. Fleming Statistical evaluation and analysis of regional interactions: the PLATO trial case study Stat Biopharm Res 5 2 2013 91 101